Breaking News

Porton Advanced Completes Series B Financing Round

The proceeds will be used to expand the company’s end-to-end gene and cell therapy platforms.

Author Image

By: Charlie Sternberg

Associate Editor

Porton Advanced Solutions has completed its Series B financing round with over $80 million.   The round of financing was led by China Merchants Groups’ healthcare PE fund Merchant Health, along with its sister fund China Merchants Capital, China Merchants Securities Investments. In addition, a number of renowned venture and private equity firms participated in the current round of financing, including Fosun Health Capital, Gortune Investment and SDICTK. Apart from the new investors, curr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters